Literature DB >> 33953368

FDA approves 100th monoclonal antibody product.

Asher Mullard.   

Abstract

Year:  2021        PMID: 33953368     DOI: 10.1038/d41573-021-00079-7

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  55 in total

Review 1.  Antibodies to watch in 2022.

Authors:  Hélène Kaplon; Alicia Chenoweth; Silvia Crescioli; Janice M Reichert
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

Review 2.  Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.

Authors:  Scott Schoen; M Sait Kilinc; Hohyun Lee; Yutong Guo; F Levent Degertekin; Graeme F Woodworth; Costas Arvanitis
Journal:  Adv Drug Deliv Rev       Date:  2021-11-18       Impact factor: 15.470

3.  Antibody-Antigen Binding Interface Analysis in the Big Data Era.

Authors:  Pedro B P S Reis; German P Barletta; Luca Gagliardi; Sara Fortuna; Miguel A Soler; Walter Rocchia
Journal:  Front Mol Biosci       Date:  2022-07-14

4.  Joined at the hip: The role of light chain complementarity determining region 2 in antibody self-association.

Authors:  Paul R Sargunas; Jamie B Spangler
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-01       Impact factor: 12.779

5.  PBPK model for antibody disposition in mouse brain: validation using large-pore microdialysis data.

Authors:  Shengjia Wu; Florie Le Prieult; Colin J Phipps; Mario Mezler; Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-09-10       Impact factor: 2.410

6.  Structures of the T cell potassium channel Kv1.3 with immunoglobulin modulators.

Authors:  Purushotham Selvakumar; Ana I Fernández-Mariño; Nandish Khanra; Changhao He; Alice J Paquette; Bing Wang; Ruiqi Huang; Vaughn V Smider; William J Rice; Kenton J Swartz; Joel R Meyerson
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

Review 7.  Expression of mammalian proteins for diagnostics and therapeutics: a review.

Authors:  Jacqueline Kar Kei Mark; Crystale Siew Ying Lim; Fazlina Nordin; Gee Jun Tye
Journal:  Mol Biol Rep       Date:  2022-06-08       Impact factor: 2.742

Review 8.  Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.

Authors:  Rossella Loria; Patrizia Vici; Francesca Sofia Di Lisa; Silvia Soddu; Marcello Maugeri-Saccà; Giulia Bon
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 9.  A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies.

Authors:  Sebastiaan C de Graaf; Max Hoek; Sem Tamara; Albert J R Heck
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

Review 10.  Antibodies to combat viral infections: development strategies and progress.

Authors:  Giuseppe Pantaleo; Bruno Correia; Craig Fenwick; Victor S Joo; Laurent Perez
Journal:  Nat Rev Drug Discov       Date:  2022-06-20       Impact factor: 112.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.